• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1期试验中向正常健康志愿者支付报酬:在公平分配研究参与负担的同时避免不当影响。

Payments to normal healthy volunteers in phase 1 trials: avoiding undue influence while distributing fairly the burdens of research participation.

作者信息

Iltis Ana S

机构信息

Health Care Ethics, Saint Louis University, St. Louis, Missouri 63103-2006, USA.

出版信息

J Med Philos. 2009 Feb;34(1):68-90. doi: 10.1093/jmp/jhn036. Epub 2009 Feb 3.

DOI:10.1093/jmp/jhn036
PMID:19190076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2682181/
Abstract

Clinical investigators must engage in just subject recruitment and selection and avoid unduly influencing research participation. There may be tension between the practice of keeping payments to participants low to avoid undue influence and the requirements of justice when recruiting normal healthy volunteers for phase 1 drug studies. By intentionally keeping payments low to avoid unduly influenced participation, investigators, on the recommendation or insistence of institutional review boards, may be targeting or systematically recruiting healthy adult members of lower socio-economic groups for participation in phase 1 studies. Investigators are at risk of routinely failing to fulfill the obligation of justice, which prohibits the systematic targeting and recruiting of subjects for reasons unrelated to the nature of the study. Insofar as we take seriously the obligation to engage in just subject recruitment and selection, I argue that we must acknowledge the implications low payments might have for subject recruitment and selection and examine the effect of low payments. If low payments de facto target the less well-off for phase 1 studies, we must defend the priority ranking of the obligation to avoid undue influence over the obligation of justice or adopt an alternative recruitment approach. This paper identifies a number of alternatives to the current system of low-value payments to research participants.

摘要

临床研究人员必须进行公正的受试者招募和选择,避免对研究参与产生不当影响。在为1期药物研究招募正常健康志愿者时,为避免不当影响而尽量降低对参与者的报酬与公正要求之间可能存在矛盾。通过故意压低报酬以避免受到不当影响的参与,研究人员在机构审查委员会的建议或坚持下,可能会针对或系统性地招募社会经济地位较低群体的健康成年成员参与1期研究。研究人员有经常未能履行公正义务的风险,公正义务禁止出于与研究性质无关的原因系统性地针对和招募受试者。鉴于我们认真对待公正进行受试者招募和选择的义务,我认为我们必须承认低报酬可能对受试者招募和选择产生的影响,并研究低报酬的效果。如果低报酬事实上使较贫困者成为1期研究的对象,我们必须捍卫避免不当影响的义务优先于公正义务的排序,或者采用另一种招募方法。本文确定了一些替代当前向研究参与者支付低价值报酬的制度的方法。

相似文献

1
Payments to normal healthy volunteers in phase 1 trials: avoiding undue influence while distributing fairly the burdens of research participation.1期试验中向正常健康志愿者支付报酬:在公平分配研究参与负担的同时避免不当影响。
J Med Philos. 2009 Feb;34(1):68-90. doi: 10.1093/jmp/jhn036. Epub 2009 Feb 3.
2
Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: a proposal.在国际资助的临床试验中补偿来自资源有限地区的临床试验参与者:一项提议。
Malawi Med J. 2008 Jun;20(2):42-5. doi: 10.4314/mmj.v20i2.10955.
3
Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement?国际试验中研究对象的获益:它们是减少了剥削还是增加了不当诱导?
Dev World Bioeth. 2008 Dec;8(3):178-91. doi: 10.1111/j.1471-8847.2006.00175.x.
4
Undue fear of inducements in research in developing countries.对发展中国家研究中诱导因素的过度担忧。
Camb Q Healthc Ethics. 2009 Apr;18(2):122-9. doi: 10.1017/S0963180109090215.
5
Exploitation in payments to research subjects.对研究对象支付款项的滥用。
Bioethics. 2011 May;25(4):209-19. doi: 10.1111/j.1467-8519.2009.01717.x.
6
Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study.为试验招募患者向医疗保健专业人员支付报酬:系统评价与定性研究
Health Technol Assess. 2008 Apr;12(10):1-128, iii. doi: 10.3310/hta12100.
7
Strategies to minimize risks and exploitation in phase one trials on healthy subjects.在健康受试者一期试验中降低风险和剥削的策略。
Am J Bioeth. 2006 May-Jun;6(3):W1-13. doi: 10.1080/15265160600686281.
8
Palliative care in phase 1 trials: an ethical obligation or undue inducement?一期试验中的姑息治疗:是道德义务还是不当诱导?
J Palliat Med. 2002 Oct;5(5):661-5. doi: 10.1089/109662102320880462.
9
Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?I 期临床试验补偿:健康志愿者参与临床试验实际能挣多少?
Clin Trials. 2021 Aug;18(4):477-487. doi: 10.1177/17407745211011069. Epub 2021 May 2.
10
Healthy volunteers and early phases of clinical experimentation.健康志愿者和临床实验早期阶段。
Eur J Clin Pharmacol. 2010 Jul;66(7):647-53. doi: 10.1007/s00228-010-0827-0. Epub 2010 May 12.

引用本文的文献

1
Public Perception of Clinical Trials and Its Predictors Among Polish Adults.波兰成年人对临床试验的公众认知及其预测因素
J Clin Med. 2025 May 8;14(10):3279. doi: 10.3390/jcm14103279.
2
The Ethics of Human Embryo Editing via CRISPR-Cas9 Technology: A Systematic Review of Ethical Arguments, Reasons, and Concerns.通过CRISPR-Cas9技术进行人类胚胎编辑的伦理问题:伦理观点、理由及担忧的系统综述
HEC Forum. 2025 Jun;37(2):267-303. doi: 10.1007/s10730-024-09538-1. Epub 2024 Sep 20.
3
Ethical Criteria for Improved Human Subject Protections in Phase I Healthy Volunteer Trials.提高 I 期健康志愿者试验中人类受试者保护的伦理标准。
Ethics Hum Res. 2022 Sep;44(5):2-21. doi: 10.1002/eahr.500139.
4
Paying for Fairness? Incentives and Fair Subject Selection.为公平付费?激励措施与公平的受试者选择
Am J Bioeth. 2021 Mar;21(3):35-37. doi: 10.1080/15265161.2020.1870766.
5
Towards a fair and transparent research participant compensation and reimbursement framework in Vietnam.迈向公平透明的越南研究参与者补偿和报销框架。
Int Health. 2020 Nov 9;12(6):533-540. doi: 10.1093/inthealth/ihaa066.
6
Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events.评价 I 期临床试验中的危害:健康志愿者对不良事件的报告。
J Law Med Ethics. 2019 Jun;47(2):323-333. doi: 10.1177/1073110519857289.
7
Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials.一项定性研究,旨在调查 I 期临床试验中健康参与者的潜在动机。
BMJ Open. 2019 Jan 15;9(1):e024224. doi: 10.1136/bmjopen-2018-024224.
8
Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.健康志愿者对参与I期临床试验益处的认知
J Empir Res Hum Res Ethics. 2018 Dec;13(5):494-510. doi: 10.1177/1556264618804962. Epub 2018 Oct 8.
9
The ethics of uninsured participants accessing healthcare in biomedical research: A literature review.无保险参与者在生物医学研究中获得医疗保健的伦理问题:文献综述。
Clin Trials. 2018 Oct;15(5):509-521. doi: 10.1177/1740774518792277. Epub 2018 Aug 2.
10
Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries.最不发达国家癌症新药研究中的研究重点与资源分配
J Oncol. 2018 Jul 2;2018:8092702. doi: 10.1155/2018/8092702. eCollection 2018.

本文引用的文献

1
The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research.《贝尔蒙报告》。保护人类研究受试者的伦理原则与准则。
J Am Coll Dent. 2014 Summer;81(3):4-13.
2
Lay concepts in informed consent to biomedical research: the capacity to understand and appreciate risk.生物医学研究知情同意中的通俗概念:理解和认识风险的能力。
Bioethics. 2006 Aug;20(4):180-90. doi: 10.1111/j.1467-8519.2006.00493.x.
3
Stakes and kidneys: why markets in human body parts are morally imperative. A reply to Horrobin.利害关系与肾脏:为何人体器官市场在道德上势在必行。对霍罗宾的回应。
Rejuvenation Res. 2006 Fall;9(3):416-8. doi: 10.1089/rej.2006.9.416.
4
In defense of a regulated market in kidneys from living vendors.为活体供肾者的肾脏规范市场辩护。
J Med Philos. 2005 Dec;30(6):593-626. doi: 10.1080/03605310500421397.
5
Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research.将研究作为治疗的一项要求:为何我们有时应允许医生向患者施压以使其参与研究。
Hastings Cent Rep. 2005 Sep-Oct;35(5):20-8.
6
Undue inducement: nonsense on stilts?不当诱导:无稽之谈?
Am J Bioeth. 2005 Sep-Oct;5(5):9-13; discussion W8-11, W17. doi: 10.1080/15265160500244959.
7
Confronting the issues of therapeutic misconception, enrollment decisions, and personal motives in genetic medicine-based clinical research studies for fatal disorders.在针对致命疾病的基于基因医学的临床研究中,直面治疗误解、入组决策和个人动机等问题。
Hum Gene Ther. 2005 Sep;16(9):1028-36. doi: 10.1089/hum.2005.16.1028.
8
Rethinking research ethics.重新思考研究伦理。
Am J Bioeth. 2005 Winter;5(1):7-28. doi: 10.1080/15265160590900678.
9
Payment of clinical research subjects.临床研究受试者的报酬。
J Clin Invest. 2005 Jul;115(7):1681-7. doi: 10.1172/JCI25694.
10
Patient autonomy and the physician's ethics.患者自主权与医生的伦理道德
Ann R Coll Physicians Surg Can. 1994 Apr;27(3):171-3.